Cargando…

Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity

Although preterm infant mortality is low, the proportion of patients with treatment-requiring retinopathy of prematurity (TR-ROP) is high in Japan. Various multicenter studies have reported the risk factors for TR-ROP; however, no large-scale studies have been conducted in Japan. We retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Suga, Shutaro, Kyono, Yuki, Kido, Takumi, Nakasone, Ruka, Abe, Shinya, Ashina, Mariko, Nozu, Kandai, Fujioka, Kazumichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098540/
https://www.ncbi.nlm.nih.gov/pubmed/35551213
http://dx.doi.org/10.1038/s41598-022-11509-w
_version_ 1784706407269924864
author Suga, Shutaro
Kyono, Yuki
Kido, Takumi
Nakasone, Ruka
Abe, Shinya
Ashina, Mariko
Nozu, Kandai
Fujioka, Kazumichi
author_facet Suga, Shutaro
Kyono, Yuki
Kido, Takumi
Nakasone, Ruka
Abe, Shinya
Ashina, Mariko
Nozu, Kandai
Fujioka, Kazumichi
author_sort Suga, Shutaro
collection PubMed
description Although preterm infant mortality is low, the proportion of patients with treatment-requiring retinopathy of prematurity (TR-ROP) is high in Japan. Various multicenter studies have reported the risk factors for TR-ROP; however, no large-scale studies have been conducted in Japan. We retrospectively analyzed 13,645 infants born at < 28 weeks’ gestation (January 1, 2009–December 31, 2018), and registered in the Neonatal Research Network of Japan database. TR-ROP was defined as ROP requiring retinal laser photocoagulation and/or intravitreal anti-vasoendothelial growth factor drugs. Multivariable logistic regression analysis was performed to identify factors associated with TR-ROP development. The median gestational age of enrolled infants was 26 weeks (interquartile range [IQR], 24–27 weeks), median birth weight was 760 g (IQR, 620–918 g). Proportion of patients with TR-ROP was 30.3%. TR-ROP was significantly associated with birth at < 26 weeks’ gestational age (adjusted odds ratio [aOR] 1.54), blood transfusion (aOR 1.49), invasive ventilation ≥ 28 days (aOR 1.41), sepsis (aOR 1.29), birth weight < 750 g (aOR 1.28), intraventricular hemorrhage (aOR 1.33), delayed achievement of full enteral feeding > 14 days (aOR 1.28), and continuous positive airway pressure (CPAP) therapy ≥ 28 days (aOR 0.79). Supplemental oxygen ≥ 28 days was not associated with TR-ROP development. Lower gestational age at birth and birth weight, blood transfusion, prolonged invasive ventilation, sepsis, intraventricular hemorrhage, and delayed achievement of full enteral feeding were risk factors for TR-ROP, whereas CPAP use was protective against TR-ROP.
format Online
Article
Text
id pubmed-9098540
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90985402022-05-14 Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity Suga, Shutaro Kyono, Yuki Kido, Takumi Nakasone, Ruka Abe, Shinya Ashina, Mariko Nozu, Kandai Fujioka, Kazumichi Sci Rep Article Although preterm infant mortality is low, the proportion of patients with treatment-requiring retinopathy of prematurity (TR-ROP) is high in Japan. Various multicenter studies have reported the risk factors for TR-ROP; however, no large-scale studies have been conducted in Japan. We retrospectively analyzed 13,645 infants born at < 28 weeks’ gestation (January 1, 2009–December 31, 2018), and registered in the Neonatal Research Network of Japan database. TR-ROP was defined as ROP requiring retinal laser photocoagulation and/or intravitreal anti-vasoendothelial growth factor drugs. Multivariable logistic regression analysis was performed to identify factors associated with TR-ROP development. The median gestational age of enrolled infants was 26 weeks (interquartile range [IQR], 24–27 weeks), median birth weight was 760 g (IQR, 620–918 g). Proportion of patients with TR-ROP was 30.3%. TR-ROP was significantly associated with birth at < 26 weeks’ gestational age (adjusted odds ratio [aOR] 1.54), blood transfusion (aOR 1.49), invasive ventilation ≥ 28 days (aOR 1.41), sepsis (aOR 1.29), birth weight < 750 g (aOR 1.28), intraventricular hemorrhage (aOR 1.33), delayed achievement of full enteral feeding > 14 days (aOR 1.28), and continuous positive airway pressure (CPAP) therapy ≥ 28 days (aOR 0.79). Supplemental oxygen ≥ 28 days was not associated with TR-ROP development. Lower gestational age at birth and birth weight, blood transfusion, prolonged invasive ventilation, sepsis, intraventricular hemorrhage, and delayed achievement of full enteral feeding were risk factors for TR-ROP, whereas CPAP use was protective against TR-ROP. Nature Publishing Group UK 2022-05-12 /pmc/articles/PMC9098540/ /pubmed/35551213 http://dx.doi.org/10.1038/s41598-022-11509-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Suga, Shutaro
Kyono, Yuki
Kido, Takumi
Nakasone, Ruka
Abe, Shinya
Ashina, Mariko
Nozu, Kandai
Fujioka, Kazumichi
Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity
title Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity
title_full Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity
title_fullStr Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity
title_full_unstemmed Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity
title_short Long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity
title_sort long use of continuous positive airway pressure protects against the development of treatment-requiring retinopathy of prematurity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098540/
https://www.ncbi.nlm.nih.gov/pubmed/35551213
http://dx.doi.org/10.1038/s41598-022-11509-w
work_keys_str_mv AT sugashutaro longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity
AT kyonoyuki longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity
AT kidotakumi longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity
AT nakasoneruka longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity
AT abeshinya longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity
AT ashinamariko longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity
AT nozukandai longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity
AT fujiokakazumichi longuseofcontinuouspositiveairwaypressureprotectsagainstthedevelopmentoftreatmentrequiringretinopathyofprematurity